MTIC
BIIB icon

Missouri Trust & Investment Company’s Biogen BIIB Stock Holding History

Missouri Trust & Investment Company’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Buy
10,795
+415
+4% +$79.4K 0.6% 38
2026
Q1 		$1.9M Buy
10,380
+1,890
+22% +$348K 0.56% 37
2025
Q4 		$1.49M Buy
8,490
+65
+0.8% +$10.6K 0.44% 52
2025
Q3 		$1.18M Buy
8,425
+615
+8% +$83.1K 0.35% 60
2025
Q2 		$981K Buy
7,810
+1,485
+23% +$185K 0.32% 63
2025
Q1 		$866K Buy
6,325
+2,460
+64% +$352K 0.3% 67
2024
Q4 		$591K Sell
3,865
-777
-17% -$131K 0.21% 81
2024
Q3 		$900K Buy
4,642
+760
+20% +$159K 0.31% 65
2024
Q2 		$900K Buy
3,882
+50
+1% +$10.9K 0.34% 63
2024
Q1 		$826K Buy
3,832
+370
+11% +$86.7K 0.32% 67
2023
Q4 		$896K Sell
3,462
-210
-6% -$51.6K 0.36% 62
2023
Q3 		$944K Buy
3,672
+1,225
+50% +$328K 0.42% 49
2023
Q2 		$697K Buy
2,447
+180
+8% +$53.6K 0.39% 65
2023
Q1 		$630K Sell
2,267
-390
-15% -$108K 0.41% 66
2022
Q4 		$736K Sell
2,657
-2
-0.1% -$565 0.44% 52
2022
Q3 		$710K Sell
2,659
-226
-8% -$48K 0.46% 48
2022
Q2 		$588K Buy
2,885
+260
+10% +$53.2K 0.38% 65
2022
Q1 		$553K Buy
2,625
+510
+24% +$111K 0.32% 67
2021
Q4 		$507K Buy
+2,115
New +$544K 0.29% 71

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Missouri Trust & Investment Company's BIIB Position: Q2 2026 in Review

Missouri Trust & Investment Company increased its Biogen (BIIB) stake by 4% in Q2 2026, buying an estimated $79.4K and bringing the position to 10,795 shares worth $2.19M. The position accounts for 0.6% of the portfolio, ranked #38.

Missouri Trust & Investment Company first reported a position in BIIB in Q4 2021 and has held it in 19 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Missouri Trust & Investment Company held 10,795 shares of Biogen worth $2.19M as of Q2 2026.
  • Missouri Trust & Investment Company bought 415 Biogen shares in Q2 2026, an estimated $79.4K.
  • Biogen made up 0.6% of Missouri Trust & Investment Company's portfolio in Q2 2026, its #38 holding.
  • Missouri Trust & Investment Company first reported a position in Biogen in Q4 2021 and has held it in 19 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q2 2026, filed 13 Aug 2026.